ArticleArchives of Razi Institute2022
Evaluation of the Biological Activity of Laboratory-Prepared Chitosan from Shrimp Shells against Pathogenic Bacterial Isolates.
Article in Archives of Razi Institute, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed, 1 citations in OpenAlex.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Chitin is the most substantial natural polysaccharide after cellulose, found in the shells of crabs, shrimps, and other crustaceans. Several medical and environmental applications have been recognized for chitosan. Therefore, the present study aimed to evaluate the biological activity of laboratory-prepared chitosan from shrimp shells against pathogenic bacteria isolates. In the present study, chitosan was extracted from chitin acetate of shrimp shells at different temperatures (room temperature, 65 and 100 ° C) for equal amounts of shells at specified time intervals. The degree of acetylation of different treatments of RT1, RT2, and RT3 reached 71%, 70%, and 65%, respectively. The laboratory-prepared chitosan was examined and antibacterial properties were observed against clinical isolates of bacterial causative agents of urinary tract infections (
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.